Combination lowers bleeding risk for bypass patients

02/28/2013 | Healio

Giving tranexamic acid with the anticoagulant clopidogrel before coronary artery bypass surgery was linked with lower odds of bleeding as well as improved platelet function, according to a study in the journal JAMA Surgery. Preoperative clopidogrel by itself was associated with increased bleeding risk and greater need for transfusions. "This extra protection [provided by tranexamic acid] against impaired platelet function improved the bleeding and transfusion outcomes in patients with clopidogrel persistence to a comparable level as that in patients with clopidogrel cessation," according to the study.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA